Sofie Peirs
University of Arizona(US)Cancer Clinic(US)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Ubiquitin and proteasome pathways, CAR-T cell therapy research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research
Most-Cited Works
- → ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia(2014)272 cited
- → A Novel l -Asparaginase with low l -Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo(2018)126 cited
- → Novel biological insights in T-cell acute lymphoblastic leukemia(2015)106 cited
- → USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia(2018)90 cited
- → ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling(2015)87 cited
- → Epigenetics in T‐cell acute lymphoblastic leukemia(2014)70 cited
- → Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia(2017)69 cited
- → PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia(2018)59 cited
- → RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia(2021)48 cited
- → Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma(2018)27 cited